{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:52:12Z","timestamp":1792291932717,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK063158"],"award-info":[{"award-number":["R01DK063158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30DK132903"],"award-info":[{"award-number":["F30DK132903"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK126487"],"award-info":[{"award-number":["R01DK126487"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","award":["T32GM007365"],"award-info":[{"award-number":["T32GM007365"]}],"id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","award":["T32GM145402"],"award-info":[{"award-number":["T32GM145402"]}],"id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.tips.2023.09.006","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:32:51Z","timestamp":1697243571000},"page":"949-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Celiac disease: mechanisms and emerging therapeutics"],"prefix":"10.1016","volume":"44","author":[{"given":"Harrison A.","family":"Besser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitan","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2023.09.006_bb0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.14309\/ajg.0000000000000523","article-title":"Incidence of celiac disease is increasing over time: a systematic review and meta-analysis","volume":"115","author":"King","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41467-022-28353-1","article-title":"An efficient urine peptidomics workflow identifies chemically defined dietary gluten peptides from patients with celiac disease","volume":"13","author":"Palanski","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2023.09.006_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.13703","article-title":"What is gluten?","volume":"32","author":"Biesiekierski","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.fm.2006.07.004","article-title":"Chemistry of gluten proteins","volume":"24","author":"Wieser","year":"2007","journal-title":"Food Microbiol."},{"key":"10.1016\/j.tips.2023.09.006_bb0030","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.1074129","article-title":"Structural basis for gluten intolerance in celiac sprue","volume":"297","author":"Shan","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.tips.2023.09.006_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00251-017-0985-7","article-title":"The roles of MHC class II genes and post-translational modification in celiac disease","volume":"69","author":"Sollid","year":"2017","journal-title":"Immunogenetics"},{"key":"10.1016\/j.tips.2023.09.006_bb0040","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1073\/pnas.0306885101","article-title":"Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease","volume":"101","author":"Kim","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2023.09.006_bb0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.gastro.2006.06.002","article-title":"A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells","volume":"131","author":"R\u00e1ki","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2019.113560","article-title":"Substrates, inhibitors, and probes of mammalian transglutaminase 2","volume":"591","author":"Zhuang","year":"2020","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tips.2023.09.006_bb0055","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acschembio.6b01155","article-title":"Celiac disease: lessons for and from chemical biology","volume":"12","author":"Khosla","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.tips.2023.09.006_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chembiol.2022.12.002","article-title":"LRP-1 links post-translational modifications to efficient presentation of celiac disease-specific T cell antigens","volume":"30","author":"Loppinet","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tips.2023.09.006_bb0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/gut.37.6.766","article-title":"Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma","volume":"37","author":"Nilsen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.tips.2023.09.006_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.med.57.051804.122404","article-title":"Celiac Disease","volume":"57","author":"Green","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.998","article-title":"Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease","volume":"43","author":"Spanish Consortium on the Genetics of Coeliac Disease (CEGEC)","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2023.09.006_bb0080","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng2058","article-title":"A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21","volume":"39","author":"Van Heel","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2023.09.006_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng.102","article-title":"Newly identified genetic risk variants for celiac disease related to the immune response","volume":"40","author":"Hunt","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2023.09.006_bb0090","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gutjnl-2011-300327","article-title":"Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis","volume":"61","author":"Heyman","year":"2012","journal-title":"Gut."},{"key":"10.1016\/j.tips.2023.09.006_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.ircmb.2020.09.007","article-title":"Epithelial cell dysfunction in coeliac disease","volume":"358","author":"Escudero-Hern\u00e1ndez","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.tips.2023.09.006_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2007.133132","article-title":"Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites","volume":"57","author":"Wapenaar","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.tips.2023.09.006_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddu453","article-title":"Systematic annotation of celiac disease loci refines pathological pathways and suggests a genetic explanation for increased interferon-gamma levels","volume":"24","author":"Kumar","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2023.09.006_bb0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2007.136366","article-title":"Mechanisms of epithelial translocation of the 2-gliadin-33mer in coeliac sprue","volume":"57","author":"Schumann","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.tips.2023.09.006_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20071204","article-title":"Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease","volume":"205","author":"Matysiak-Budnik","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2008.03.023","article-title":"Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3","volume":"135","author":"Lammers","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.aah5298","article-title":"Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease","volume":"356","author":"Bouziat","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.tips.2023.09.006_bb0130","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2006.00741.x","article-title":"Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study","volume":"101","author":"Stene","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0135","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/INF.0000000000001600","article-title":"Rotavirus vaccination and the risk of celiac disease or type 1 diabetes in Finnish children at early life","volume":"36","author":"Vaarala","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.tips.2023.09.006_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/INF.0000000000002281","article-title":"Rotavirus vaccination does not increase type 1 diabetes and may decrease celiac disease in children and adolescents","volume":"38","author":"Hemming-Harlo","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.tips.2023.09.006_bb0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/gutjnl-2014-306931","article-title":"The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease","volume":"64","author":"Olivares","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.tips.2023.09.006_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41594-019-0353-4","article-title":"T cell receptor cross-reactivity between gliadin and bacterial peptides in celiac disease","volume":"27","author":"Petersen","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2023.09.006_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033387","article-title":"Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants","volume":"7","author":"Sellitto","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2023.09.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020322118","article-title":"Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study","volume":"118","author":"Leonard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2023.09.006_bb0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba0624","article-title":"Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation","volume":"12","author":"Lamas","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrgastro.2015.90","article-title":"Novel players in coeliac disease pathogenesis: role of the gut microbiota","volume":"12","author":"Verdu","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0175","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.immuni.2023.06.022","article-title":"The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells","volume":"56","author":"Medina Sanchez","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2023.09.006_bb0180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0753-3322(01)80003-2","article-title":"Histopathology of celiac disease","volume":"54","author":"Oberhuber","year":"2000","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2023.09.006_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jcp.36.2.149","article-title":"Studies of intestinal lymphoid tissue. VI. Proliferative response of small intestinal epithelial lymphocytes distinguishes gluten- from non-gluten-induced enteropathy","volume":"36","author":"Marsh","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tips.2023.09.006_bb0190","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cell.2018.12.039","article-title":"Chronic inflammation permanently reshapes tissue-resident immunity in celiac disease","volume":"176","author":"Mayassi","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.tips.2023.09.006_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4312","article-title":"Gluten induces rapid reprogramming of natural memory \u03b1\u03b2 and \u03b3\u03b4 intraepithelial T cells to induce cytotoxicity in celiac disease","volume":"8","author":"Kornberg","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tips.2023.09.006_bb0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tips.2023.09.006_bb0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature09849","article-title":"Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens","volume":"471","author":"DePaolo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.006_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A Direct Role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"H\u00fce","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2023.09.006_bb0215","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.tips.2023.09.006_bb0220","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1084\/jem.20071887","article-title":"Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15","volume":"206","author":"Tang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0225","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.coi.2005.09.015","article-title":"Is celiac disease an autoimmune disorder?","volume":"17","author":"Sollid","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.tips.2023.09.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200852","article-title":"Longevity, clonal relationship, and transcriptional program of celiac disease-specific plasma cells","volume":"218","author":"Lindeman","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathmechdis-031521-032634","article-title":"The immunobiology and pathogenesis of celiac disease","volume":"18","author":"Iversen","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.tips.2023.09.006_bb0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm.2656","article-title":"High abundance of plasma cells secreting transglutaminase 2\u2013specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions","volume":"18","author":"Di Niro","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0245","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/j.gastro.2018.12.013","article-title":"Plasma cells are the most abundant gluten peptide MHC-expressing cells in inflamed intestinal tissues from patients with celiac disease","volume":"156","author":"H\u00f8ydahl","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0250","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41586-022-04916-6","article-title":"Immune tolerance of food is mediated by layers of CD4+ T cell dysfunction","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.006_bb0255","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/pbi.12455","article-title":"Targeting of prolamins by RNAi in bread wheat: effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins","volume":"14","author":"Barro","year":"2016","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.tips.2023.09.006_bb0260","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3390\/nu13124548","article-title":"Oral consumption of bread from an RNAi wheat line with strongly silenced gliadins elicits no immunogenic response in a pilot study with celiac disease patients","volume":"13","author":"Guzm\u00e1n-L\u00f3pez","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.tips.2023.09.006_bb0265","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1053\/j.gastro.2011.10.038","article-title":"The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues","volume":"142","author":"Pinier","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109972","article-title":"BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity. D\u2019Auria S, editor","volume":"9","author":"McCarville","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2023.09.006_bb0275","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1021\/jf205319s","article-title":"In vitro and in vivo binding activity of chicken egg yolk immunoglobulin Y (IgY) against gliadin in food matrix","volume":"60","author":"Gujral","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.tips.2023.09.006_bb0280","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10620-016-4426-5","article-title":"AGY, a novel egg yolk-derived anti-gliadin antibody, is safe for patients with celiac disease","volume":"62","author":"Sample","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2023.09.006_bb0285","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2007.05.028","article-title":"Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue","volume":"133","author":"Gass","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0290","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.chembiol.2006.04.009","article-title":"Rational design of combination enzyme therapy for celiac sprue","volume":"13","author":"Siegel","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2023.09.006_bb0295","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","article-title":"The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo","volume":"134","author":"Tye-Din","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tips.2023.09.006_bb0300","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, tolerability, and activity of ALV003: results from two Phase 1 single, escalating-dose clinical trials","volume":"57","author":"Siegel","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2023.09.006_bb0305","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"L\u00e4hdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0310","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2022.07.071","article-title":"Latiglutenase protects the mucosa and attenuates symptom severity in patients with celiac disease exposed to a gluten challenge","volume":"163","author":"Murray","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0315","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0320","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1007\/s10620-017-4687-7","article-title":"Latiglutenase improves symptoms in seropositive celiac disease patients while on a gluten-free diet","volume":"62","author":"Syage","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.tips.2023.09.006_bb0325","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gut.2006.111609","article-title":"Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease","volume":"57","author":"Mitea","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.tips.2023.09.006_bb0330","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2021.03.019","article-title":"Gluten degradation, pharmacokinetics, safety, and tolerability of TAK-062, an engineered enzyme to treat celiac disease","volume":"161","author":"Pultz","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0335","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of Kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions","volume":"137","author":"Wolf","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2023.09.006_bb0340","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot study","volume":"19","author":"Tack","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0345","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.05.003","article-title":"Transglutaminase 2 inhibitors and their therapeutic role in disease states","volume":"115","author":"Siegel","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tips.2023.09.006_bb0350","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/cells11101667","article-title":"Features of ZED1227: the first-in-class tissue transglutaminase inhibitor undergoing clinical evaluation for the treatment of celiac disease","volume":"11","author":"B\u00fcchold","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tips.2023.09.006_bb0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A randomized trial of a transglutaminase 2 inhibitor for celiac disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0360","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.bmc.2007.10.091","article-title":"Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with celiac disease","volume":"16","author":"Kapoerchan","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.006_bb0365","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/mi.2010.44","article-title":"Single-chain recombinant HLA-DQ2.5\/peptide molecules block \u03b12-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease","volume":"4","author":"Huan","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.tips.2023.09.006_bb0370","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmc.2007.07.001","article-title":"Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease","volume":"15","author":"Xia","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tips.2023.09.006_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg4925","article-title":"A high-affinity human TCR-like antibody detects celiac disease gluten peptide\u2013MHC complexes and inhibits T cell activation","volume":"6","author":"Frick","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tips.2023.09.006_bb0380","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"L\u00e4hdeaho","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0385","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0390","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/382366a0","article-title":"Critical role for \u03b27 integrins in formation of the gut-associated lymphoid tissue","volume":"382","author":"Wagner","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.tips.2023.09.006_bb0395","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/j.gastro.2020.01.045","article-title":"Gliadin nanoparticles induce immune tolerance to gliadin in mouse models of celiac disease","volume":"158","author":"Freitag","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0400","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/wnan.1263","article-title":"Targeted immunomodulation using antigen-conjugated nanoparticles: targeted immunomodulation","volume":"6","author":"McCarthy","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.tips.2023.09.006_bb0405","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaut.2017.12.010","article-title":"Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells","volume":"89","author":"Prasad","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tips.2023.09.006_bb0410","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0415","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","volume":"26","author":"Daveson","year":"2017","journal-title":"eBioMedicine"},{"key":"10.1016\/j.tips.2023.09.006_bb0420","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade5800","article-title":"Identification of gluten T cell epitopes driving celiac disease","volume":"9","author":"Chlubnov\u00e1","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2023.09.006_bb0425","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0430","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/apt.15477","article-title":"Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease","volume":"50","author":"Tye-Din","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.tips.2023.09.006_bb0435","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41591-019-0403-9","article-title":"Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions","volume":"25","author":"Christophersen","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0440","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tips.2023.09.006_bb0445","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/s41598-019-43426-w","article-title":"Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease","volume":"9","author":"Freire","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2023.09.006_bb0450","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MPG.0000000000003835","article-title":"Gluten immunogenic peptides are not correlated with reported adherence to gluten-free diet in children with celiac disease","volume":"77","author":"Guz-Mark","year":"2023","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.tips.2023.09.006_bb0455","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2004.tb06058.x","article-title":"Coeliac disease: the great imitator","volume":"180","author":"Duggan","year":"2004","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.tips.2023.09.006_bb0460","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/j.1572-0241.2008.01977.x","article-title":"Age-related clinical, serological, and histopathological features of celiac disease","volume":"103","author":"Vivas","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0465","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2020.06.098","article-title":"Epidemiology, presentation, and diagnosis of celiac disease","volume":"160","author":"Lebwohl","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0470","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.39133.668681.BE","article-title":"Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool","volume":"334","author":"Hopper","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.tips.2023.09.006_bb0475","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14309\/ajg.0000000000002075","article-title":"American College of Gastroenterology guidelines update: diagnosis and management of celiac disease","volume":"118","author":"Rubio-Tapia","year":"2023","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0480","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.tips.2023.09.006_bb0485","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2010.10","article-title":"Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet","volume":"105","author":"Rubio-Tapia","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0490","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.dld.2010.05.009","article-title":"Five year time course of celiac disease serology during gluten free diet: results of a community based \u2018CD-Watch\u2019 program","volume":"42","author":"Zanini","year":"2010","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.tips.2023.09.006_bb0495","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.tips.2023.09.006_bb0500","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.clnu.2016.05.002","article-title":"Gluten free diet and nutrient deficiencies: a review","volume":"35","author":"Vici","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.tips.2023.09.006_bb0505","first-page":"82","article-title":"Health benefits and adverse effects of a gluten-free diet in non-celiac disease patients","volume":"14","author":"Niland","year":"2018","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"10.1016\/j.tips.2023.09.006_bb0510","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ajg.2011.104","article-title":"The incidence and clinical spectrum of refractory celiac disease in a North American referral center","volume":"106","author":"Roshan","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2023.09.006_bb0515","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gtc.2018.09.010","article-title":"Refractory celiac disease","volume":"48","author":"Malamut","year":"2019","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.tips.2023.09.006_bb0520","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5009\/gnl.2009.3.4.237","article-title":"Adult celiac disease and its malignant complications","volume":"3","author":"Freeman","year":"2009","journal-title":"Gut Liver"},{"key":"10.1016\/j.tips.2023.09.006_bb0525","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archpedi.1924.04120220017004","article-title":"The value of the banana in the treatment of celiac disease","volume":"28","author":"Haas","year":"1924","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0530","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1651-2227.1953.tb05563.x","article-title":"Coeliac disease the presence in wheat of a factor having a deleterious effect in cases of coeliac disease","volume":"42","author":"Dicke","year":"1953","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.tips.2023.09.006_bb0535","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(56)92137-7","article-title":"Jejunal-biopsy tube","volume":"267","author":"Shiner","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2023.09.006_bb0540","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02231100","article-title":"Intraluminal biopsy of the small intestine: the intestinal biopsy capsule","volume":"2","author":"Crosby","year":"1957","journal-title":"Digest. Dis. Sci."},{"key":"10.1016\/j.tips.2023.09.006_bb0545","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(59)92051-3","article-title":"Gluten-induced enteropathy the effect of partially digested gluten","volume":"274","author":"Frazer","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2023.09.006_bb0550","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/BF01479129","article-title":"Diagnostische Bewertung des Nachweises von Gliadin-Antik\u00f6rpern bei C\u00f6liakie","volume":"42","author":"Berger","year":"1964","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.tips.2023.09.006_bb0555","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0016-5085(92)91819-P","article-title":"Gluten, major histocompatibility complex, and the small intestine","volume":"102","author":"Marsh","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2023.09.006_bb0560","first-page":"205","article-title":"Immunocytes, enterocytes and the lamina propria: an immunopathological framework of coeliac disease","volume":"17","author":"Marsh","year":"1983","journal-title":"J. R. Coll. Physicians Lond."},{"key":"10.1016\/j.tips.2023.09.006_bb0565","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.1984.tb06601.x","article-title":"IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease","volume":"111","author":"Chorzelski","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tips.2023.09.006_bb0570","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.169.1.345","article-title":"Evidence for a primary association of celiac disease to a particular HLA-DQ alpha\/beta heterodimer","volume":"169","author":"Sollid","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0575","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.178.1.187","article-title":"Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients","volume":"178","author":"Lundin","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0580","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0585","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2023.09.006_bb0590","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/gut.2004.059998","article-title":"T cells in peripheral blood after gluten challenge in coeliac disease","volume":"54","author":"Anderson","year":"2005","journal-title":"Gut."},{"key":"10.1016\/j.tips.2023.09.006_bb0595","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-020-2003-8","article-title":"IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease","volume":"578","author":"Abadie","year":"2020","journal-title":"Nature"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723002080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614723002080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:17:13Z","timestamp":1759051033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614723002080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0165614723002080"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2023.09.006","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celiac disease: mechanisms and emerging therapeutics","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2023.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}